CellWise has released its Q3 2026 report, showing revenue of RMB 147 million, up 17.08% year-over-year. Non-GAAP net profit came in at RMB 10.36 million, down 51.03% year-over-year. R&D expenses rose 22.36% year-over-year to RMB 44.14 million, accounting for 30.01% of total revenue.
